Archive: 30/11/2012

Clinical trial delivers good results in leukemia patients

Huntsman Cancer Institute (HCI) researchers Michael Deininger, M.D., Ph.D., and Thomas O'Hare, Ph.D., were part of a team that found a potent oral drug, ponatinib, effective in patients who have developed resistance to standard ...

Nov 30, 2012
popularity0 comments 0

As cigarette taxes go up, heavy smoking goes down

(Medical Xpress)—When cigarette taxes rise, hard-core smokers are more likely than lighter smokers to cut back, according to new research from Washington University School of Medicine in St. Louis.

Nov 30, 2012
popularity0 comments 0

Managing cellular security systems

Conventional dendritic cells (cDCs) are the immune system's patrol. They recognize foreign threats and trigger a defensive response, while restraining immune reactions against inappropriate targets like host proteins. They ...

Nov 30, 2012
popularity0 comments 0

Mistletoe as treatment for colon cancer?

(Medical Xpress)—Mistletoe has become an important symbol of Christmas but it also has the potential to play a vital role as an alternative therapy for Australian sufferers of colon cancer.

Nov 30, 2012
popularity1 comments 0